Biofrontera Inc. – NASDAQ:BFRIW

Biofrontera stock price today

$0.122
+0.03
+42.6%
Financial Health
0
1
2
3
4
5
6
7
8
9

Biofrontera stock price monthly change

+141.93%
month

Biofrontera stock price quarterly change

+141.93%
quarter

Biofrontera stock price yearly change

+743.14%
year

Biofrontera key metrics

Market Cap
9.66M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-13.1
Revenue
33.22M
EBITDA
-21.88M
Income
-23.09M
Revenue Q/Q
-9.52%
Revenue Y/Y
20.13%
Profit margin
-2.23%
Oper. margin
-64.8%
Gross margin
47.04%
EBIT margin
-64.8%
EBITDA margin
-65.88%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Biofrontera stock price history

Biofrontera stock forecast

Biofrontera financial statements

Biofrontera Inc. (NASDAQ:BFRIW): Profit margin
Jun 2023 5.84M -9.83M -168.21%
Sep 2023 8.87M -6.34M -71.43%
Dec 2023 10.59M 3.52M 33.28%
Mar 2024 7.90M -10.43M -132.1%
Biofrontera Inc. (NASDAQ:BFRIW): Debt to assets
Jun 2023 36905000 29.73M 80.56%
Sep 2023 34104000 33.06M 96.96%
Dec 2023 27932000 23.13M 82.84%
Mar 2024 24575000 29.99M 122.04%
Biofrontera Inc. (NASDAQ:BFRIW): Cash Flow
Jun 2023 -10.33M 178K 1.10M
Sep 2023 -2.00M 382K 591K
Dec 2023 -8.86M 73K 6.71M
Mar 2024 -3.32M 0 5.79M

Biofrontera alternative data

Biofrontera Inc. (NASDAQ:BFRIW): Employee count
Jan 2024 81
Feb 2024 81
Mar 2024 83
Apr 2024 83
May 2024 83
Jun 2024 83
Jul 2024 83

Biofrontera other data

1.41% +0.38%
of BFRIW is owned by hedge funds
320.45K +87.39K
shares is hold by hedge funds
  • What's the price of Biofrontera stock today?

    One share of Biofrontera stock can currently be purchased for approximately $0.12.

  • When is Biofrontera's next earnings date?

    Unfortunately, Biofrontera's (BFRIW) next earnings date is currently unknown.

  • Does Biofrontera pay dividends?

    No, Biofrontera does not pay dividends.

  • How much money does Biofrontera make?

    Biofrontera has a market capitalization of 9.66M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 18.82% to 34.07M US dollars.

  • What is Biofrontera's stock symbol?

    Biofrontera Inc. is traded on the NASDAQ under the ticker symbol "BFRIW".

  • What is Biofrontera's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Biofrontera?

    Shares of Biofrontera can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Biofrontera have?

    As Jul 2024, Biofrontera employs 83 workers.

  • What is Biofrontera's official website?

    The official website for Biofrontera is biofrontera-us.com.

  • How can i contact Biofrontera?

    Biofrontera can be reached via phone at +7 812451325.

Biofrontera company profile:

Biofrontera Inc.

biofrontera-us.com
Exchange:

NASDAQ

Full time employees:

83

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

120 Presidential Way
Woburn, 01801

CIK: 0001858685
ISIN: US09077D1182
CUSIP: 09077D118